Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Amortization of Deferred Charges (2018 - 2020)

Historic Amortization of Deferred Charges for Dna X (SONM) over the last 3 years, with Q4 2020 value amounting to -$169000.0.

  • Dna X's Amortization of Deferred Charges fell 15331.23% to -$169000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $166000.0, marking a year-over-year decrease of 7904.04%. This contributed to the annual value of $166000.0 for FY2020, which is 5476.84% down from last year.
  • Per Dna X's latest filing, its Amortization of Deferred Charges stood at -$169000.0 for Q4 2020, which was down 15331.23% from $169000.0 recorded in Q3 2020.
  • In the past 5 years, Dna X's Amortization of Deferred Charges ranged from a high of $386000.0 in Q3 2018 and a low of -$169000.0 during Q4 2020
  • In the last 3 years, Dna X's Amortization of Deferred Charges had a median value of $228000.0 in 2018 and averaged $168222.2.
  • Per our database at Business Quant, Dna X's Amortization of Deferred Charges soared by 25617.98% in 2019 and then tumbled by 15331.23% in 2020.
  • Over the past 3 years, Dna X's Amortization of Deferred Charges (Quarter) stood at $89000.0 in 2018, then skyrocketed by 256.18% to $317000.0 in 2019, then plummeted by 153.31% to -$169000.0 in 2020.
  • Its Amortization of Deferred Charges stands at -$169000.0 for Q4 2020, versus $169000.0 for Q3 2020 and -$89000.0 for Q2 2020.